Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $244,842.48 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 2,104 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $116.37, for a total transaction of $244,842.48. Following the transaction, the chief financial officer now directly owns 20,647 shares of the company’s […]
More Stories
The Herzfeld Caribbean Basin Fund Inc. (NASDAQ:CUBA) Sees Large Increase in Short Interest
The Herzfeld Caribbean Basin Fund Inc. (NASDAQ:CUBA – Get Free Report) was the target of a significant increase in short...
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIEW) Short Interest Up 21.5% in December
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIEW – Get Free Report) saw a large increase in short interest during the month...
Azincourt Energy (CVE:AAZ) Shares Down 33.3% – Here’s What Happened
Azincourt Energy Corp. (CVE:AAZ – Get Free Report) shares traded down 33.3% during trading on Tuesday . The company traded...
Sensient Technologies Co. (NYSE:SXT) Sees Large Increase in Short Interest
Sensient Technologies Co. (NYSE:SXT – Get Free Report) was the recipient of a significant increase in short interest in December....
UGI Co. (NYSE:UGI) Sees Large Increase in Short Interest
UGI Co. (NYSE:UGI – Get Free Report) saw a significant increase in short interest in the month of December. As...
Short Interest in Pioneer Power Solutions, Inc. (NASDAQ:PPSI) Increases By 24.8%
Pioneer Power Solutions, Inc. (NASDAQ:PPSI – Get Free Report) was the target of a significant increase in short interest in...